| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/2004 | EP1385484A2 Compositions and methods of manufacture for oral dissolvable dosage forms |
| 02/04/2004 | EP1385483A1 Fast disintegrating meloxicam tablet |
| 02/04/2004 | EP1385482A1 An effervescent solid composition of matter |
| 02/04/2004 | EP1385476A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 02/04/2004 | EP1385473A1 Use of oligomeric proanthrocyanidins |
| 02/04/2004 | EP1385465A2 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
| 02/04/2004 | EP1385459A2 Transdermal delivery of pergolide |
| 02/04/2004 | EP1339416A4 Trace elements |
| 02/04/2004 | EP1296947B1 $g(A) CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT |
| 02/04/2004 | EP1289369A4 Phytonutrient formula for the relief of chronic pain resulting from inflammation |
| 02/04/2004 | EP1267847B1 5ht 2 agonists for controlling iop and treating glaucoma |
| 02/04/2004 | EP1237549B1 Lipoxin a4 and analogues for the treatment of dry eye |
| 02/04/2004 | EP1216041B1 High lipid diet |
| 02/04/2004 | EP1203585A4 Anti-ischemic agent |
| 02/04/2004 | EP1196409B1 Respiratory syncytial virus replication inhibitors |
| 02/04/2004 | EP1189615B1 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines |
| 02/04/2004 | EP1180024B1 Z-styryl sulfone anticancer agents |
| 02/04/2004 | EP1141124B1 Anionic-cationic polyion complexes comprising zwitterionic monomer component |
| 02/04/2004 | EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 02/04/2004 | EP1076650B1 Aryl fused azapolycyclic compounds |
| 02/04/2004 | EP1042319B1 Dihydrobenzofurans |
| 02/04/2004 | EP1035859B1 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents |
| 02/04/2004 | EP1030839B1 Use of alkylated iminosugars to treat multidrug resistance |
| 02/04/2004 | EP1024784A4 Beta-d glucan topical composition |
| 02/04/2004 | EP1014926B1 Therapeutic and cosmetic compositions, their use and method for the preparation thereof |
| 02/04/2004 | EP1010424B1 Liver fat accumulation inhibitory composition, food additive for liver fat accumulation inhibition, and method of inhibiting liver fat accumulation |
| 02/04/2004 | EP1007055B1 Use of amifostine |
| 02/04/2004 | EP0994888B1 Process for the acylation of amino alcohols |
| 02/04/2004 | EP0992503B1 Process for producing isooxazolidinedione compound |
| 02/04/2004 | EP0992495B1 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride |
| 02/04/2004 | EP0988324B1 Method for manufacturing pure guar meal |
| 02/04/2004 | EP0960139B1 Elastomer treatment process to decrease peroxide levels |
| 02/04/2004 | EP0848755B9 Vegf-related protein |
| 02/04/2004 | EP0831838B1 Use of vitamin d 4 derivatives for treating skin disorders |
| 02/04/2004 | EP0820414B1 Metered dose inhaler for beclomethasone dipropionate |
| 02/04/2004 | EP0783326B1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 02/04/2004 | EP0684816B1 5-ht2 receptor antagonists for treating venous conditions |
| 02/04/2004 | EP0642507B1 Transition state analogues of cocaine, their use for producing catalytic antibodies against cocaine and use of the same in diagnosis and therapy |
| 02/04/2004 | CN1473265A Method for producing purified hematinic iron-saccharidic complex and product produced |
| 02/04/2004 | CN1473214A Method for production of low defect density silicon |
| 02/04/2004 | CN1473213A Process for preparing low defect density silicon using high growth rates |
| 02/04/2004 | CN1473163A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473160A Indole derivatives as medicinal compositions for antifungal and/or antiparasitic agents |
| 02/04/2004 | CN1473156A Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 02/04/2004 | CN1473154A Phthalazinone derivatives |
| 02/04/2004 | CN1473151A Crystalline forms of fluvastatin sodium |
| 02/04/2004 | CN1473150A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/04/2004 | CN1473144A Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines with taurine chloride and glycine chloride |
| 02/04/2004 | CN1473061A Antithrombotic compositions |
| 02/04/2004 | CN1473055A Methods for enhancing efficacy of cytotoxic agents through use of HSP90 inhibitors |
| 02/04/2004 | CN1473053A High-density lipoprotein-cholesterol level elevating agent |
| 02/04/2004 | CN1473048A 1 alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 02/04/2004 | CN1473047A Method for treating hypogonadism |
| 02/04/2004 | CN1473046A Improved treatment |
| 02/04/2004 | CN1473045A Process for preparation of dinapsoline |
| 02/04/2004 | CN1473044A Inhalative solution formulation containing tiotropium salt |
| 02/04/2004 | CN1473043A Method for treating allergies using substituted pyrazoles |
| 02/04/2004 | CN1473042A Medical compositions |
| 02/04/2004 | CN1473040A Association and medicinal composition of CB1 receptor antagonist and sibutramin for treating obesity |
| 02/04/2004 | CN1473039A Remedies for heratoconjunctival diseases containing farnesyl acetate as the active ingredient |
| 02/04/2004 | CN1473038A Inhalative solution formulation containing tiotropium salt |
| 02/04/2004 | CN1473037A Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
| 02/04/2004 | CN1473035A Compositions containing substained-release fine grains for tablets quickly disintegrable in oral cavity and process for producing same |
| 02/04/2004 | CN1472337A Reagent box, method software and composite medicine for predicting effect of ACEI hypotensors |
| 02/04/2004 | CN1472336A SARS coronavirus 3Cl protease two-dimensional model and medicine preventing SARS |
| 02/04/2004 | CN1472235A Folic acid-polydiol compound and its medicinal composition |
| 02/04/2004 | CN1472220A Triterpene extracts from achyranthes roots and their use in medicine against osteoporosis |
| 02/04/2004 | CN1472217A Aminoglucose acid, chromium complex with its derivative and preparation and use thereof |
| 02/04/2004 | CN1472214A Composition of ginkgo internal ester B and its preparation and use thereof |
| 02/04/2004 | CN1472210A Compound for treating sexual dysfunction |
| 02/04/2004 | CN1472209A ²-carboline and sulfo-analogues subsitituted for amino-acid radical, preparing method and application thereof |
| 02/04/2004 | CN1472208A Aromatic heterocyclic carboxylic acid derivative, preparing method and application in medicine |
| 02/04/2004 | CN1471973A Notoginseng saponine immunological component and vaccin preparation containing it |
| 02/04/2004 | CN1471960A Preparation of xinxue granules |
| 02/04/2004 | CN1471957A Moschus safflower capsules for activating blood and generating bone |
| 02/04/2004 | CN1471941A Chinese medicine haemorrhoids ointment |
| 02/04/2004 | CN1471923A Spray for treating asthma and its preparing method |
| 02/04/2004 | CN1471922A Spray contaniing heparin and lipoid, preparing method thereof |
| 02/04/2004 | CN1471921A Use of chitin oligosaccharide sulphate and/or chitin sulfate for preparing medicine for diabetes |
| 02/04/2004 | CN1471920A Compound antimicrobial medicine containing N-acetophenetidin-D-chitosamine |
| 02/04/2004 | CN1471919A Use of allose alcohol in preparing medicine for diabetes |
| 02/04/2004 | CN1471918A Oral liquid medicine for benzopirnie phosphate and its preparing method |
| 02/04/2004 | CN1471917A Western medicine vitamin mixture for Meniere's disease |
| 02/04/2004 | CN1471916A Medicnial composition containing biphenyl lambral for treating superficial mycosis |
| 02/04/2004 | CN1471915A Powder injection of diflucan and its preparing method |
| 02/04/2004 | CN1471914A Medicine, application and preparing method for preventnig SARS pneumonia by SARS virus |
| 02/04/2004 | CN1471913A Micro-pillet preparation of ranitidine |
| 02/04/2004 | CN1471912A Oral film agent of vanadium biguanide complex for diabetes and its use |
| 02/04/2004 | CN1471911A Oral film agent of vanadium biguanide complex for diabetes and its use |
| 02/04/2004 | CN1471910A Preparing method for suspensoid of complete trans vitamin A acid |
| 02/04/2004 | CN1471909A High-capacitance |
| 02/04/2004 | CN1471908A Sesquiterpene ketone injection, preparing method and use thereof |
| 02/04/2004 | CN1137136C Targeted cytotoxic anthracycline analogs |
| 02/04/2004 | CN1137134C Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 02/04/2004 | CN1137133C Preparation of sterol and dihydro-sterol ester |
| 02/04/2004 | CN1137130C Schizophyllum tetrasaccharide-alkyl glycoside compound and its prepn and application |
| 02/04/2004 | CN1137129C Schizophyllary tetrasaccharide cluster compound and its preparing method and use |
| 02/04/2004 | CN1137125C Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 02/04/2004 | CN1137123C Azolo triazizes and pyrimidines |